Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism

Yu Min Lin, Hsun Jin Jan, Chin Cheng Lee, Hsiao Yi Tao, Yu Lueng Shih, Hen Wei Wei, Horng Mo Lee

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Dexamethasone has been shown to inhibit tumor invasiveness. In the present study, the effects of dexamethasone on matrix metalloproteinases-2 (MMP-2) secretion, cell invasiveness, and intravasation in human U87MG glioma cells were examined. Dexamethasone decreased MMP-2 secretion and cell invasiveness in human glioma cells. Incubation of cells with dexamethasone increased mitogen activated protein kinase phosphatase-1 (MKP-1) expression. Ectopic expression of MKP-1 decreased cell invasiveness in vitro and intravasation in vivo. Because expression of inducible nitric oxide synthase (iNOS) has been implicated in the progression of malignant gliomas, we next investigated the possible roles of NO- in MMP-2 secretion and cell invasiveness in human U87MG glioma cells. Treatment of glioma cells with nitric oxide donor, sodium nitroprusside (SNP), increased MMP-2 secretion and the capacity of cell invasion in U87MG cells. Addition of dexamethasone or ectopic expression of wild-type MKP-1 suppressed the SNP-stimulated MMP-2 activation and glioma cell invasiveness in U87MG cells. Taken together, these results suggest that dexamethasone may suppress MMP-2 secretion and cell invasion through MKP-1 induction in human glioma cells.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalEuropean Journal of Pharmacology
Volume593
Issue number1-3
DOIs
Publication statusPublished - Sep 28 2008

Fingerprint

Dual Specificity Phosphatase 1
Glioblastoma
Dexamethasone
Matrix Metalloproteinase 2
Glioma
Nitroprusside
Mitogen-Activated Protein Kinase Phosphatases
Nitric Oxide Donors

Keywords

  • Dexamethasone
  • Glioma
  • Invasiveness
  • MKP-1
  • MMP-2

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism. / Lin, Yu Min; Jan, Hsun Jin; Lee, Chin Cheng; Tao, Hsiao Yi; Shih, Yu Lueng; Wei, Hen Wei; Lee, Horng Mo.

In: European Journal of Pharmacology, Vol. 593, No. 1-3, 28.09.2008, p. 1-9.

Research output: Contribution to journalArticle

Lin, Yu Min ; Jan, Hsun Jin ; Lee, Chin Cheng ; Tao, Hsiao Yi ; Shih, Yu Lueng ; Wei, Hen Wei ; Lee, Horng Mo. / Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism. In: European Journal of Pharmacology. 2008 ; Vol. 593, No. 1-3. pp. 1-9.
@article{22d6ac5b36b7414a9cb467638d35d81d,
title = "Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism",
abstract = "Dexamethasone has been shown to inhibit tumor invasiveness. In the present study, the effects of dexamethasone on matrix metalloproteinases-2 (MMP-2) secretion, cell invasiveness, and intravasation in human U87MG glioma cells were examined. Dexamethasone decreased MMP-2 secretion and cell invasiveness in human glioma cells. Incubation of cells with dexamethasone increased mitogen activated protein kinase phosphatase-1 (MKP-1) expression. Ectopic expression of MKP-1 decreased cell invasiveness in vitro and intravasation in vivo. Because expression of inducible nitric oxide synthase (iNOS) has been implicated in the progression of malignant gliomas, we next investigated the possible roles of NO- in MMP-2 secretion and cell invasiveness in human U87MG glioma cells. Treatment of glioma cells with nitric oxide donor, sodium nitroprusside (SNP), increased MMP-2 secretion and the capacity of cell invasion in U87MG cells. Addition of dexamethasone or ectopic expression of wild-type MKP-1 suppressed the SNP-stimulated MMP-2 activation and glioma cell invasiveness in U87MG cells. Taken together, these results suggest that dexamethasone may suppress MMP-2 secretion and cell invasion through MKP-1 induction in human glioma cells.",
keywords = "Dexamethasone, Glioma, Invasiveness, MKP-1, MMP-2",
author = "Lin, {Yu Min} and Jan, {Hsun Jin} and Lee, {Chin Cheng} and Tao, {Hsiao Yi} and Shih, {Yu Lueng} and Wei, {Hen Wei} and Lee, {Horng Mo}",
year = "2008",
month = "9",
day = "28",
doi = "10.1016/j.ejphar.2008.06.111",
language = "English",
volume = "593",
pages = "1--9",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism

AU - Lin, Yu Min

AU - Jan, Hsun Jin

AU - Lee, Chin Cheng

AU - Tao, Hsiao Yi

AU - Shih, Yu Lueng

AU - Wei, Hen Wei

AU - Lee, Horng Mo

PY - 2008/9/28

Y1 - 2008/9/28

N2 - Dexamethasone has been shown to inhibit tumor invasiveness. In the present study, the effects of dexamethasone on matrix metalloproteinases-2 (MMP-2) secretion, cell invasiveness, and intravasation in human U87MG glioma cells were examined. Dexamethasone decreased MMP-2 secretion and cell invasiveness in human glioma cells. Incubation of cells with dexamethasone increased mitogen activated protein kinase phosphatase-1 (MKP-1) expression. Ectopic expression of MKP-1 decreased cell invasiveness in vitro and intravasation in vivo. Because expression of inducible nitric oxide synthase (iNOS) has been implicated in the progression of malignant gliomas, we next investigated the possible roles of NO- in MMP-2 secretion and cell invasiveness in human U87MG glioma cells. Treatment of glioma cells with nitric oxide donor, sodium nitroprusside (SNP), increased MMP-2 secretion and the capacity of cell invasion in U87MG cells. Addition of dexamethasone or ectopic expression of wild-type MKP-1 suppressed the SNP-stimulated MMP-2 activation and glioma cell invasiveness in U87MG cells. Taken together, these results suggest that dexamethasone may suppress MMP-2 secretion and cell invasion through MKP-1 induction in human glioma cells.

AB - Dexamethasone has been shown to inhibit tumor invasiveness. In the present study, the effects of dexamethasone on matrix metalloproteinases-2 (MMP-2) secretion, cell invasiveness, and intravasation in human U87MG glioma cells were examined. Dexamethasone decreased MMP-2 secretion and cell invasiveness in human glioma cells. Incubation of cells with dexamethasone increased mitogen activated protein kinase phosphatase-1 (MKP-1) expression. Ectopic expression of MKP-1 decreased cell invasiveness in vitro and intravasation in vivo. Because expression of inducible nitric oxide synthase (iNOS) has been implicated in the progression of malignant gliomas, we next investigated the possible roles of NO- in MMP-2 secretion and cell invasiveness in human U87MG glioma cells. Treatment of glioma cells with nitric oxide donor, sodium nitroprusside (SNP), increased MMP-2 secretion and the capacity of cell invasion in U87MG cells. Addition of dexamethasone or ectopic expression of wild-type MKP-1 suppressed the SNP-stimulated MMP-2 activation and glioma cell invasiveness in U87MG cells. Taken together, these results suggest that dexamethasone may suppress MMP-2 secretion and cell invasion through MKP-1 induction in human glioma cells.

KW - Dexamethasone

KW - Glioma

KW - Invasiveness

KW - MKP-1

KW - MMP-2

UR - http://www.scopus.com/inward/record.url?scp=49749083806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49749083806&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2008.06.111

DO - 10.1016/j.ejphar.2008.06.111

M3 - Article

C2 - 18652821

AN - SCOPUS:49749083806

VL - 593

SP - 1

EP - 9

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -